Fulminant type 1 diabetes with high‐titer anti‐glutamic acid decarboxylase antibodies: Likely rapid progression from stage 2 to 3

Documenti analoghi

• Letter to the Editor in response to the article “Prediction of future insulin deficiency in glutamic acid decarboxylase autoantibody enzyme‐linked immunosorbent assay‐positive patients with slowly progressive type 1 diabetes”
  di: Ciyu Zhao
  Pubblicazione: (2025)
• Cross‐sectional association of irregular dietary habits with glycemic control and body mass index among people with diabetes
  di: Mika Shimizu, et al.
  Pubblicazione: (2024)
• Clinical characteristics of anti‐neurofascin 155 antibody‐positive autoimmune nodopathy in children
  di: Liya Cui, et al.
  Pubblicazione: (2025)
• Life‐threatening acute complications persist among individuals with type 1 diabetes in Japan: A nationwide registry‐based cross‐sectional study
  di: Daisuke Chujo, et al.
  Pubblicazione: (2026)
• The prevalence of hepatitis B infection and anti‐HCV antibody in patients with diabetes mellitus
  di: Malihe Naderi, et al.
  Pubblicazione: (2025)